Loperamide for treatment of acute diarrhoea in infants and young children. A double-blind placebo-controlled trial
Abstract
High-dose loperamide reduces stool output and shortens the duration of diarrhoea in infants receiving intravenous fluids for rehydration, but may cause potentially harmful side-effects in a small number of patients. This double-blind placebo-controlled study was undertaken to assess whether loperami …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
Infant
Clinical Trial
Double-Blind Method
length of stay
diarrhea
controlled clinical trial
infantile / drug therapy
pmid:8545750
m d bowie
i d hill
m d mann
antidiarrheals / administration & dosage*
antidiarrheals / adverse effects
loperamide / administration & dosage*
loperamide / adverse effects
Access
Citation
ID:
116553
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
116553
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet